Citius Oncology, Inc. (CTOR)
Healthcare
Drug Manufacturers - Specialty & Generic
0.59 $
+3.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Citius Oncology, Inc. (CTOR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 19.1% of the shares are freely tradable; institutional investors hold 15.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
15.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
79.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
19.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
93Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.88 | 9,188,855 | +64.6 | 03/31/2026 |
| Bank of America Corp | 4.12 | 3,835,160 | +1,792,030.8 | 03/31/2026 |
| Vanguard Group Inc | 0.64 | 596,997 | +231.4 | 12/31/2025 |
| Vanguard Capital Management, LLC | 0.58 | 534,824 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.28 | 264,733 | +20.3 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.13 | 121,910 | +0.0 | 03/31/2026 |
| IFP Advisors, LLC | 0.12 | 107,424 | +22.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 0.40 | 370,100 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.19 | 176,225 | +7.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.12 | 115,119 | -0.4 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.